头孢曲松他唑巴坦钠联合盐酸氨溴索治疗老年急性肺炎的临床疗效观察

Clinical effect observation of ceftriaxone and tazobactam sodium combining with ambroxol hydrochloride in the treatment of elderly patients with acute pneumonia

目的探讨头孢曲松他唑巴坦钠联合盐酸氨溴索治疗老年急性肺炎的临床疗效。方法本院2011年10月～2012年1月收治的78例患者,经确诊为急性肺炎,随机分为治疗组和对照组。治疗组应用头孢曲松他唑巴坦钠联合盐酸氨溴索治疗,对照组应用盐酸左氧氟沙星治疗。结果治疗组有效率、X线胸片炎症吸收率及细菌清除率明显优于对照组。结论头孢曲松他唑巴坦钠联合盐酸氨溴索治疗老年急性肺炎比应用盐酸左氧氟沙星疗效确切,并能有效地克服单一用药的不足,值得临床推广使用。

Objective To explore the clinical effects of ceftriaxone and tazobactam sodium combining with ambroxol hydrochlofide in the treatment of elderly patients with acute pneumonia （AP）. Methods Data from 78 patients admitted into our hospital and diagnosed as AP from October 2011 to January 2012 were retrospectively analyzed and randomly divided into treatment group （ceftriaxone and tazobactam sodium combining with ambroxol hydrochloride） and control group （levofloxacin hydrochloride）. Results In the treatment group, the total effective rate, X-ray absorption rate of inflammation, and bacteriological clearance rate were all superior to those in the control group. Conclusion In comparison with the levofloxacin hydrochloride group, patients in the ceftriaxone and tazobactam sodium combining with ambroxol hydrochloride group not only get better effect, but also effectively overcome shortcomings of single medication, which is worthy of widespread application in clinic